News & Events
Read our latest research news, explore upcoming events and find resources describing our mission and programs.
Latest News
NCATS Stories

Electronic Consent Summary Form Creates More Participant-Focused Process, Speeds Clinical Trial Enrollment
March 27, 2025 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
- Helping to End Addiction Long-term® Initiative (HEAL)
- Our Impact on Clinical Trials
An electronic consent summary form used for a clinical trial created a clearer and more efficient process and was well received by participants.
Read Article
NCATS Team Creates Novel Computational Pipeline to Find New Ways to Treat Glioblastoma
March 10, 2025 - NCATS News
- Analytical Chemistry
- Biomedical Data Translator (Translator)
- Informatics (IFX)
- Our Impact on Drug Discovery and Development
- Our Impact on Rare Diseases
NCATS scientists tested a new method that could identify existing drugs effective against glioblastoma, a type of brain cancer that currently has no adequate treatments and a very low five-year survival rate.
Read ArticlePartner & Grantee News
AI Innovations Enhance Behavioural Health Care Delivery
April 9, 2025 - Grantee/Partner News
- Our Impact on Tools and Technologies
SC Governor Honors MUSC Researcher for Her Work to Make Behavioral Health Care More Accessible
April 8, 2025 - Grantee/Partner News
- Small Business (SBIR)
Hospitalization Offers Chance to Begin Treatment for Patients With Opioid Use Disorder
April 7, 2025 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Upcoming Events
NIH Rare Pair: Rare Disease Treatments Partnering Workshop
July 24, 2025 - July 25, 2025 - Workshop
Location: Mass General Brigham, Boston, Massachusetts
Join us for the NIH Rare Pair: Rare Disease Treatments Partnering Workshop, a pivotal event bringing together key contributors in the rare diseases ecosystem. Hosted by the National Institutes of Health (NIH), this workshop will take place July 24–25, 2025, at Mass General Brigham in Boston, Massachusetts.
This unique gathering will explore the rare diseases commercialization landscape from the diverse perspectives of industry leaders, private investors, government funders and patient advocacy organizations. Attendees will engage in dynamic panels and discussions addressing the challenges, opportunities and critical areas of interest in developing novel therapies for rare diseases.
Key highlights of the workshop include the following:
- Interactive Panels and Discussions: Gain insights into overcoming barriers and maximizing opportunities in the rare diseases treatment space.
- Rare Diseases Therapy Pitch Session: Listen to innovative NIH-supported investigators presenting cutting-edge treatments for rare diseases.
- Networking Opportunities: Build meaningful connections with researchers, investors and strategic partners driving advances in rare disease therapeutics.
Whether you’re a researcher, investor, advocate or industry professional, this workshop offers a unique opportunity to collaborate and accelerate the development of groundbreaking treatments for rare diseases.
Save the date and be part of the conversation that transforms ideas into treatments for patients with rare diseases.
Registration information and agenda will be coming soon.
Publications
Browse a listing of peer-reviewed scientific publications that feature research supported by NCATS programs and initiatives.
Matching Lines to Designs: A Novel Radiographic Index for Shorter Femoral Stems in Total Hip Arthroplasty
Clinical and Translational Science Awards (CTSA) Program - December 1, 2025 - Journal of Orthopaedics
Read PublicationIdentifying Commonalities and Differences Between EHR Representations of PASC and ME/CFS in the RECOVER EHR Cohort
Clinical and Translational Science Awards (CTSA) Program - April 11, 2025 - Communications Medicine
Read PublicationLipoprotein(a) and Risk of Incident Atherosclerotic Cardiovascular Disease: Impact of High-Sensitivity C-Reactive Protein and Risk Variability Among Human Clinical Subgroups
Clinical and Translational Science Awards (CTSA) Program - April 11, 2025 - Nutrients
Read PublicationClaudin-17 Deficiency Drives Vascular Permeability and Inflammation Causing Lung Injury
Clinical and Translational Science Awards (CTSA) Program - April 11, 2025 - International Journal of Molecular Sciences
Read PublicationNegative Affect Influences the Computations Underlying Food Choice in Bulimia Nervosa
Clinical and Translational Science Awards (CTSA) Program - April 8, 2025 - eLife
Read PublicationCommon-Variant and Rare-Variant Genetic Architecture of Heart Failure Across the Allele-Frequency Spectrum
Clinical and Translational Science Awards (CTSA) Program - April 7, 2025 - Nature Genetics
Read PublicationImpact of Propranolol and Psychologically Informed Intervention on Pain Sensitivity: Secondary Analysis From the Biopsychosocial Influence on Shoulder Pain Preclinical Randomized Trial
Clinical and Translational Science Awards (CTSA) Program - April 5, 2025 - Journal of Pain Research
Read PublicationInflammatory Signaling Pathways Play a Role in SYK Inhibitor Resistant AML
Division of Preclinical Innovation - April 5, 2025 - Scientific Reports
Read PublicationCommunity Pharmacist-Administered Injectable Naltrexone for Individuals Who Were Formerly Incarcerated: A Review of Wisconsin Legislation and Regulations
Clinical and Translational Science Awards (CTSA) Program - April 5, 2025 - Substance Abuse Treatment, Prevention, and Policy
Read PublicationLatent Class Analysis Identifies Risk Groups to Model the Expected Benefits of SARS-CoV-2 Interventions Among University Students
Clinical and Translational Science Awards (CTSA) Program - April 2, 2025 - Scientific Reports
Read Publication